Price Alert

Vor Biopharma Inc. (VOR)

NASDAQ: VOR · Real-Time Price · USD

2.04

0.00 (0.00%)

At close: Aug 19, 2025, 11:45 AM

0.00% (1D)

Bid	1.49
Market Cap	257.8M
Revenue (ttm)	n/a
Net Income (ttm)	-118.6M
EPS (ttm)	-13.68
PE Ratio (ttm)	-0.15
Forward PE	-4.39
Analyst	Hold

Ask	2.54
Volume	1,171,178
Avg. Volume (20D)	18,044,224
Open	2.05
Previous Close	2.04
Day's Range	1.97 - 2.08
52-Week Range	0.13 - 3.29
Beta	2.06

About VOR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VOR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

6 days ago

+21.69%

Vor Bio shares are trading higher after the compan... Unlock content with Pro Subscription

6 days ago

+21.69%

Vor Biopharma shares are trading higher following the release of its Q2 reported financial results.

News

5 days ago · benzinga.com

Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate

Vor Bio VOR stock is trading higher on Wednesday with a session volume of 10.83 million compared to the average volume of 17.99 million, as per data from Benzinga Pro.

1 month ago · benzinga.com

Vor Biopharma's RemeGen Deal Paves Way For Multi-Billion Dollar Autoimmune Market

H.C. Wainwright upgraded Vor Biopharma Inc. VOR, highlighting the company's “rebirth” following the in-licensing of telitacicept.

1 month ago · zacks.com

Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why

The VOR stock soars in the past week after a licensing deal with RemeGen. The company also appoints a chief executive officer and chairman.